The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

  • OptimisticPrime@lemmy.fmhy.ml
    link
    fedilink
    arrow-up
    2
    ·
    edit-2
    1 year ago

    Sure, but treatments of something that complex has to start somewhere. It seems to go in the right direction and upcoming treatments may build on that. I am not sure that anyone could have expected after many failures to just find the magical cure that completely cures Alzheimers.